Cargando…

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

Detalles Bibliográficos
Autores principales:	Adriani, Giulia, Cappello, Paola, Lovisa, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569458/ https://www.ncbi.nlm.nih.gov/pubmed/37841424 http://dx.doi.org/10.3389/fonc.2023.1289756

Ejemplares similares

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
por: Salemme, Vincenzo, et al.
Publicado: (2023)

Tumor heterogeneity: preclinical models, emerging technologies, and future applications
por: Proietto, Marco, et al.
Publicado: (2023)

Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Editorial: Novel Targets and Targeting Technologies to Modulate Tumor Microenvironment
por: Prakash, Jai, et al.
Publicado: (2016)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics
por: Pirini, Francesca, et al.
Publicado: (2022)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Characterization of the Tumor Microenvironment and Tumor–Stroma Interaction by Non-invasive Preclinical Imaging
por: Ramamonjisoa, Nirilanto, et al.
Publicado: (2017)

Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment
por: Giustarini, Giulio, et al.
Publicado: (2023)

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
por: Wang, Lishun, et al.
Publicado: (2023)

Editorial: The effects of chemotherapy towards the tumor microenvironment
por: Abu, Nadiah, et al.
Publicado: (2022)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

Editorial: Plasticity of immune cells in tumor microenvironment
por: Oksenych, Valentyn
Publicado: (2023)

Brain Microenvironment Heterogeneity: Potential Value for Brain Tumors
por: Álvaro-Espinosa, Laura, et al.
Publicado: (2021)

Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
por: Cavazzoni, Andrea, et al.
Publicado: (2023)

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
por: Pasello, Giulia, et al.
Publicado: (2022)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Editorial: GBM stem cells and the brain tumor microenvironment
por: Li, Yunqing, et al.
Publicado: (2023)

Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment
por: Matamala Montoya, María, et al.
Publicado: (2023)

Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models
por: Morris, Elysse K., et al.
Publicado: (2023)

Editorial: The tumor microenvironment and malignant properties in primary liver cancer
por: Qu, Chen
Publicado: (2023)

Emerging Understanding of Multiscale Tumor Heterogeneity
por: Gerdes, Michael J., et al.
Publicado: (2014)

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
por: Zhang, Aiping, et al.
Publicado: (2022)

Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment
por: Chen, Yun-Wang, et al.
Publicado: (2022)

Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment
por: Milan, Enrico, et al.
Publicado: (2023)

Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies
por: Liao, Rui, et al.
Publicado: (2022)

Editorial: Impact of Cancer Plasticity on Drug Resistance and Treatment in Solid Tumors
por: Cohen, Pascale A., et al.
Publicado: (2020)

The Tumor Microenvironment and Strategies to Improve Drug Distribution
por: Saggar, Jasdeep K., et al.
Publicado: (2013)

The emerging roles of Hedgehog signaling in tumor immune microenvironment
por: Wang, Juan, et al.
Publicado: (2023)

Editorial: Emerging Biomarkers in Genitourinary Tumors
por: Montironi, Rodolfo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ifedcquso5rkhg8ar0c8hua0ba